More Business Wire
View Older Stories View Newer Stories-
LTM Partners with Anthropic to Accelerate Claude Adoption and Expand Enterprise Delivery
-
NUBURU Announces Proposed Premium-Priced Public Offering Expected to Provide Sufficient Funding to Consummate the Acquisition of a Controlling Interest in Tekne and Extinguish Outstanding Indebtedness
-
Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer
-
Enhanced Athlete Beatriz Pirón Breaks World Record Just Six Weeks After Injury Following a Highly Personalized Recovery and Enhancement Protocol
-
TIME Names Aramark Among America's Best Companies 2026
-
Veteran Entertainment Executive and Industry Dealmaker Ron Bension Joins VENU as Strategic Advisor to CEO
-
PENN Entertainment Launches theScore Bet Sportsbook & Casino and theScore Casino and Hollywood Casino Standalone Apps in Alberta
-
Comvest Private Equity Rebrands as Vesterra Capital Partners
-
Ravee Optics Secures $6 Million Seed Round as the Need to Move More Data in Space Explodes
-
Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery
-
Perk Becomes First to Connect Travel, Spend, Invoicing and Events Through a Single MCP
-
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis
-
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
-
Capital Square Fully Subscribes Richmond Active-Adult DST Offering
-
CareXM and OnePoint Patient Care Partner to Get Medications to Hospice Patients Faster After Hours
-
Fastmail Launches EU-Hosted Email Infrastructure, Giving Customers Control Over Where Their Data Lives
-
Alliance Resource Partners, L.P. Announces Second Quarter 2026 Earnings Conference Call
-
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
-
AECOM selected to help advance major rail transportation project in Australia, The Wave – Stage 1
-
The GEO Group Announces Contract for Company-Leased 1,188-Bed Big Horn Facility in Colorado
-
N-able Appoints Cybersecurity Sales Veteran Russell Rosa as Chief Revenue Officer to Drive Upmarket Expansion and Accelerate Partner-Led Growth Across the Channel
-
All Three Independent Proxy Advisory Firms Recommend Genesco Shareholders Vote “FOR” All Nine of Genesco’s Directors
-
Eaton to announce second quarter 2026 earnings on July 31, 2026
-
Babcock & Wilcox Board Authorizes Share Repurchase Program of Up to $50 Million
-
Silvia Surpasses $50 Billion in Assets in 14 Months Since Public Launch
-
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026
-
Babcock & Wilcox Announces Full Redemption of Notes
-
Perfect Corp. to Announce Financial Results for Second Quarter of 2026 on July 27, 2026
-
Collision Partners Acquires K&M Collision, Adds Michael Bradshaw to Executive Leadership Team
-
Drug Farm Completes First Closing of $55 Million Series D Financing to Advance Clinical and Preclinical Development Pipeline
-
Emera Declares Quarterly Dividends
-
Vertical Aerospace Shares Business Update Ahead of Farnborough International Airshow
-
NOG Provides Second Quarter Operational Update
-
Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer
-
Mill Point Capital Completes the Acquisition of Total Safety Supplies & Solutions
-
Zip Opens New York City Hub, Plans to Double Local Team
-
Zayed Sustainability Prize Closes 2027 Submissions with Strong Global Participation
-
Genethon’s Recent Accomplishments Underscore the Progress of Genetic Medicine from Scientific Promise to Clinical Reality
-
Cadeler Announces Signing of an EIFO-Backed Green Term Loan Facility of EUR 247 Million for Wind Apex
-
Ant Group Open-Sources SingGuard-NSFA to Establish New Security Paradigms for Autonomous AI Agents
-
Beaconcure Names Seth Houston as Chief Executive Officer to Lead Next Phase of Growth
-
KBRA Releases Research – Private Credit: NAV Loans Evolve as Product Goes Mainstream
-
Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types
-
Europe’s Demand for Tech Services Accelerates in Q2, As Spending on AI and Managed Services Rises: ISG Index™
-
Maureen Mahr von Staszewski Joins Heitman European Leadership Team
-
Marti and Tensor Partner to Deploy Autonomous Vehicles in Türkiye
-
PropertyStream and Offr Launch TRANSACT as UK Homebuying Enters the Digital Era
-
LTM Partners with Anthropic to Accelerate Claude Adoption and Expand Enterprise Delivery
-
Sofinnova Partners Appoints David Evans as Partner
-
PureTech Founded Entity Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
